Scipher Medicine
Contact
Search
Platform
Solutions
Company
Latest
Careers
Contact
Join Us
Publications
All articles
Press Releases
Publications
News Articles
Media Kit
Show all
Press Releases
Publications
News Articles
Media Kit
11/4/22
Publications
Patient outcomes improve when a molecular signature test guides treatment decision-making in rheumatoid arthritis
6/1/22
Publications
Evaluation of physician global assessment in patients with b/tsDMARD therapy selection aligned with a molecular signature response classifier: an analysis from The Study to Accelerate Information of Molecular Signatures (AIMS) in Rheumatoid Arthritis
3/29/22
Publications
Budget Impact and Clinical Outcomes of a Molecular Signature to Inform TNFi Treatment Selection in Commercial Patients with Rheumatoid Arthritis
3/16/22
Publications
Network-based response module comprised of gene expression biomarkers predicts response to infliximab at treatment initiation in ulcerative colitis
12/30/21
Publications
Clinical utility of therapy selection informed by predicted nonresponse to tumor necrosis factor-ɑ inhibitors: an analysis from the Study to Accelerate Information of Molecular Signatures (AIMS) in rheumatoid arthritis
12/1/21
Publications
Guided therapy selection in rheumatoid arthritis using a molecular signature response classifier: an assessment of budget impact and clinical utility
11/10/21
Publications
A molecular signature response classifier to predict inadequate response to tumor necrosis factor-α Inhibitors: the NETWORK-004 Prospective Observational Study
11/8/21
Publications
Discontinuation of TNFi treatment among Rheumatoid Arthritis patients with a molecular signature of non-response to tumor necrosis factor-ɑ inhibitor therapies
11/8/21
Publications
A molecular signature response classifier predicts the likelihood of non-response to TNF inhibitor therapies in RA at 3 months
10/26/21
Publications
Analytical and clinical validation of an RNA sequencing-based assay for quantitative, accurate evaluation of a molecular signature response classifier in rheumatoid arthritis
10/1/21
Publications
A network medicine approach to discover common novel drug target mechanisms across autoimmune diseases
9/8/21
Publications
A molecular signature response classifier stratifies seropositive rheumatoid arthritis patients based on their likelihood of inadequate response to TNF inhibitor therapies
6/10/21
Publications
A high-confidence definition of therapeutic response in rheumatoid arthritiss using a Monte Carlo simulation approach
6/10/21
Publications
A molecular signature response classifier predicts the likelihood of eular nonresponse to TNF inhibitor therapies in RA: results from a retrospective cohort analysis
3/30/21
Publications
Network medicine framework for identifying drug-repurposing opportunities for COVID-19
Posts navigation
1
2
Next